Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Jun 2010 11:38

RNS Number : 7921N
Oxford Biomedica PLC
17 June 2010
 



For immediate release

17 June 2010

 

Oxford BioMedica Plc

Notification of Major Interest in Shares

 

TR-1: Notifications of Major Interests in Shares

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Oxford BioMedica Plc

 

2. Reason for notification (yes/no)

 

An acquisition or disposal of voting rights

Yes

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to notification obligation:

 

Legal & General Group Plc (L&G)

 

4. Full name of shareholder(s) (if different from 3):

Legal & General Assurance (Pensions Management) Limited (PMC)

 

5. Date of transaction (and date on which the threshold is crossed or reached if different):

 

15 June 2010

 

6. Date on which issuer notified:

 

16 June 2010

 

7. Threshold(s) that is/are crossed or reached:

 

From 4% to 3%

 

8: Notified Details

A: Voting rights attached to shares

 

Class/type of shares

If possible use ISIN code GB0006648157

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

 

 

Number of shares 22,476,084

 

Number of voting rights 22,476,084

Number of shares 21,605,215

Number of voting rights

Percentage of voting rights

Direct 21,605,215

 Indirect

 

 Direct 3.98%

 Indirect

B: Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Expiration date

Exercise/ conversion period/date

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

 

 

Total (A+B)

 

Number of voting rights

Percentage of voting rights

21,605,215

3.98%

 

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

 

Legal & General Group Plc (Direct and Indirect) (Group)

 

Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)

 

Legal & General Investment Management Limited (Indirect) (LGIM)

 

Legal & General Group Plc (Direct) (L&G) ( 21,605,215 - 3.97%= LGAS, LGPL & PMC)

Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD) (19,907,441 - 3.66%= PMC)

Legal & General Insurance Holdings Limited (Direct) (LGIH)

Legal & General Assurance (Pensions Management) Limited (PMC) ( 19,907,441 - 3.66%= PMC)

Legal & General Assurance Society Limited (LGAS & LGPL)

Legal & General Pensions Limited (Direct) (LGPL)

 

Proxy Voting:

10. Name of proxy holder:

 

11. Number of voting rights proxy holder will cease to hold:

 

12. Date on which proxy holder will cease to hold voting rights:

 

 

13. Additional information:

 

14 Contact name:

 

Andrew Wood

15. Contact telephone number:

 

01865 783000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBORRRNANAAR
Date   Source Headline
7th Jun 20167:00 amRNSNew Non-Exclusive LentiVector Licence with MolMed
6th Jun 20163:29 pmRNSOXB to Present at Jefferies Healthcare Conference
2nd Jun 201610:05 amRNSR&D Partnership with Green Cross LabCell
2nd Jun 20169:30 amRNSTotal Voting Rights
24th May 201610:08 amRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSDeferred Bonus Plan and LTIP Option Grants
17th May 20167:00 amRNSOxford BioMedica Appoints Corporate Broker
16th May 20169:23 amRNSDirector/PDMR Shareholding
16th May 20169:16 amRNSDirector/PDMR Shareholding
12th May 20167:00 amRNSOxford BioMedica Board Change
6th May 201612:21 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSLong-Term Expression of LentiVector
5th May 20165:50 pmRNS2015 Annual Report and Accounts & AGM Notification
5th May 20169:22 amRNSDirector/PDMR Shareholding
4th May 20168:48 amRNSDirector/PDMR Shareholding
3rd May 201612:57 pmRNSDirector/PDMR Shareholding
3rd May 20169:25 amRNSTotal Voting Rights
29th Apr 20161:35 pmRNSDirector Shareholding
28th Apr 20167:00 amRNSPreliminary Results for the Year Ended 31 Dec 2015
26th Apr 20167:00 amRNSStuart Henderson Appointed as a NED
25th Apr 20168:48 amRNSDirector/PDMR Shareholding
15th Apr 20168:50 amRNSHolding(s) in Company
1st Apr 20169:01 amRNSTotal Voting Rights
24th Mar 20169:27 amRNSDirector Dealings
11th Mar 20164:28 pmRNSHolding(s) in Company
7th Mar 20167:00 amRNSImmune Design Collaboration and Licence Expanded
1st Mar 201611:04 amRNSTotal Voting Rights
1st Mar 20169:46 amRNSHolding(s) in Company
1st Mar 20169:44 amRNSHolding(s) in Company
1st Mar 20169:38 amRNSNotice of Preliminary Results date: 28 April 2016
29th Feb 201612:16 pmRNSDirector/PDMR Shareholding
26th Feb 20164:42 pmRNSHolding(s) in Company
25th Feb 20165:16 pmRNSDirector/PDMR Shareholding
25th Feb 20162:46 pmRNSHolding(s) in Company
25th Feb 20162:45 pmRNSDirector/PDMR Shareholding
25th Feb 20169:36 amRNSHolding(s) in Company
23rd Feb 20167:00 amRNSPlacing to raise £8.1 Million
16th Feb 201610:59 amRNSHolding(s) in Company
11th Feb 20164:40 pmRNSSecond Price Monitoring Extn
11th Feb 20164:35 pmRNSPrice Monitoring Extension
2nd Feb 20169:37 amRNSTotal Voting Rights
29th Jan 20167:00 amRNSInitiation of Second CART Programme for Novartis
13th Jan 20167:00 amRNSMHRA approval to manufacture in new facility
5th Jan 20167:00 amRNSDirectorate Change
4th Jan 20167:00 amRNSBlocklisting Interim Review
4th Jan 20167:00 amRNSTotal Voting Rights
21st Dec 20152:11 pmRNSTotal Voting Rights
15th Dec 20157:00 amRNSAppointment of New Chairman
2nd Dec 201511:14 amRNSTotal Voting Rights
30th Nov 201511:32 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.